Robert T Foster
CIK 1677370 · CEO and Director · last filed 2023-09-22
Robert T Foster is a CEO and Director who has filed 11 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for AUPH, was dated Sep 22, 2023. Across all open-market trades the lifetime net is +$97.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.0K
3
11
$97.0K
Holdings By Company
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-22 | AUPH | Grant (A) | — | $0 | EDGAR |
| 2023-09-19 | HEPA | Buy (P) | +1,600 | $9.0K | EDGAR |
| 2023-09-18 | HEPA | Buy (P) | +1,600 | $8.6K | EDGAR |
| 2021-05-20 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2021-02-18 | HEPA | Buy (P) | +20,000 | $40.0K | EDGAR |
| 2020-12-08 | HEPA | Buy (P) | +25,000 | $39.4K | EDGAR |
| 2020-08-21 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2020-04-07 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2019-07-25 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2018-01-05 | Hepion Pharmaceuticals, Inc. (CTRV) Delisted | Grant (A) | +100,654 | $0 | EDGAR |